Tissue Regenix Group PLC
LSE:TRX
Tissue Regenix Group PLC
LSE:TRX
Price:
0.0725
GBX
Market Cap:
£5.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Tissue Regenix Group PLC
LSE:TRX
|
UK |
|
H
|
HERC Products Inc
OTC:HERC
|
US |
|
Gyldendal ASA
OSE:GYL
|
NO |
|
Ibex Ltd
NASDAQ:IBEX
|
US |
|
360 Ludashi Holdings Ltd
HKEX:3601
|
CN |
|
M
|
Micro Friend Inc
KOSDAQ:147760
|
KR |
|
Arcadyan Technology Corp
TWSE:3596
|
TW |
|
AEye Inc
NASDAQ:LIDR
|
US |
|
Jinjian Cereals Industry Co Ltd
SSE:600127
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of TRX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRX
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
TRX Competitors Multiples
Tissue Regenix Group PLC Competitors
Tissue Regenix Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Tissue Regenix Group PLC
LSE:TRX
|
5.2m GBP | 0.3 | -5.1 | 41.6 | -24.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.2 | 90 | 14.9 | 20.7 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 109.7 | -1 712.3 | 15 906.4 | -1 796.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.4 | 28.5 | 21.4 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
